Jan 14th, 2022
Main Events to present late-breaking science
The latest stroke science research will be presented in New Orleans.
During ISC 2022' s Main Events, abstract presenters will provide their latest science research, covering the gamut of stroke findings.
Main Event 1
11 a.m.-12:30 p.m. CT
Wednesday, Feb. 9
- Randomized Clinical Trial of Endovascular Therapy for Acute Large Vessel Occlusion With Large Ischemic Core
- Endovascular Treatment With Versus Without Tirofiban For Stroke Patients With Large Vessel Occlusion: The Multicenter, Randomized, Placebo-Controlled, Double-Blind RESCUE BT Clinical Trial
- PeRiodontal Treatment to Eliminate Minority Inequality and Rural Disparities in Stroke (PREMIERS) study
Main Event II
11 a.m.-12:30 p.m. CT
Thursday, Feb. 10
- Economic Evaluation of the Benefits of Stroke Treatment Delivered Using a Mobile Stroke Unit Study
- Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study
- A Randomized Trial of Intra-Arterial Alteplase After Successful Thrombectomy in Acute Ischemic Stroke
- Tenecteplase Thrombolysis for Stroke up to 24 Hours After Onset With Perfusion Imaging Selection
- Onyx™ Embolization for the Endovascular Management of Cerebral Arteriovenous Malformations: Short and Long-Term Clinical Results of a Prospective Multicenter Study
Main Event III
11 a.m.-12:30 p.m. CT
Friday, Feb. 11
- Novel Robotic-Assisted Transcranial Doppler Versus Transthoracic Echocardiography to Detect Right-to-Left Shunts
- Primary Results and Associated Clot Composition in the Excellent Registry
- Sex Difference in the Impact of Dual Antiplatelet Therapy Using Cilostazol for Secondary Stroke Prevention
- Pediatric Large Vessel Occlusion Stroke: Poor Outcomes Without Intervention
- Outcomes of Efficiency Techniques During Mechanical Thrombectomy in Acute Ischemic Stroke Assist Global Registry Analysis
